跳至主要内容
临床试验/ISRCTN16890855
ISRCTN16890855进行中(未招募)Unknown

The impact of a holistic multifactorial management intervention in adults with early-onset type 2 diabetes (aged 16 to 45 years): the M3 randomized controlled trial

niversity of Leicester0 个研究点目标入组 246 人开始时间: 2023年5月22日最近更新:

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
246

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 16 to 45 years, inclusive
  • 2. Type 2 diabetes diagnosed before the age of 40 years; confirmed by medical history with/without specialist investigations (e.g., antibodies)
  • 3. HbA1c >= 6.0% (>= 42 mmol/mol) within 3 months of trial enrolment
  • 4. Able to provide informed consent

排除标准

  • 1. Diagnosed with other forms of diabetes (e.g., type 1 diabetes, monogenic diabetes [MODY], gestational diabetes or latent autoimmune diabetes in adults [LADA])
  • 2. Serious illness or event with life-expectancy <1 year or other significant illness which, in the opinion of a study clinician, precludes involvement
  • 3. Planned major surgery
  • 4. Requirement for renal replacement therapy
  • 5. Current pregnancy, or actively trying to conceive
  • 6. Unable or unwilling to provide informed consent
  • 7. Current participation in a competing clinical trial (CTIMP, as determined by the study investigator)

研究者

发起方
niversity of Leicester

相似试验